A alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder) DMF (Drug Master File) is a document detailing the whole manufacturing process of alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder) active pharmaceutical ingredient (API) in detail. Different forms of alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder) DMFs exist exist since differing nations have different regulations, such as alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder) DMF submitted to regulatory agencies in the US is known as a USDMF. alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder) USDMF includes data on alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder) suppliers with USDMF on PharmaCompass.